Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Vet Ophthalmol. 2010 Jul;13(4):211–218. doi: 10.1111/j.1463-5224.2010.00782.x

Figure 7.

Figure 7

Western blot analysis showing quantitative measurement of α-SMA (myofibroblast marker) in ECF treated with or without TGFβ1 (1ng/ml) and 0.02% MMC. Equal quantity of protein (50 μg) was loaded in each lane. GAPDH was used as house keeping gene. A single early MMC treatment showed significant decrease in TGFβ1-induced myofibroblast formation in ECF compared to untreated controls. The late MMC treatment showed moderate reduction in α-SMA.